Renal Pelvis and Ureter Carcinoma — Trials

Renal Pelvis and Ureter Carcinoma — Trials · CancerIndex

Clinical trials

Registered studies

105 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

Active: 48
Recruiting: 27
Ph III recruiting: 6
Growth YoY: —
Industry share: 10%
Top sponsor: National Cancer Institute (NCI)
Termination share: —

Computedformula ci-trial-intel-v1 · interventional studies · entity + NCIt descendants · hover a figure for its formulaCompare cancers Terminated studies (8)

clinicaltrialsPublishedShowing 51–65 of 65 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT04724018	Sacituzumab Govitecan Plus EV in Metastatic UC	recruiting	Phase 1 / Phase 2	106	Dana-Farber Cancer InstituteOTHER	1	Nov 4, 2025	clinicaltrials
NCT06848868	Ambulatory Flexible URS for UTUC Surveillance	recruiting	Phase 1	10	Chinese University of Hong KongOTHER	1	Sep 15, 2025	clinicaltrials
NCT07126119